Meeting with the Minister of Healthcare of the Republic of Kazakhstan: MIT presented advanced solutions for the development of the country’s oncology service

Within the framework of the X Congress of Oncologists and Radiologists of Kazakhstan, a working meeting was held with the participation of the Minister of Healthcare of the Republic of Kazakhstan Akmaral Alnazarova, Chairman of the Board of Kazakh Institute of Oncology and Radiology Yerbol Bekmukhambetov, Chairman of the Supervisory Board of Medical Innovative Technologies Mikhail Guterman, as well as representatives of the professional community and industry experts.

Medical Innovative Technologies presented its current projects and strategic initiatives aimed at developing the oncology service in the country, including plans for the implementation of the Comprehensive Oncology Development Plan and approaches to equipping clinics with modern medical equipment. Special emphasis was placed on a systematic approach to healthcare infrastructure modernization, where equipment supply, its integration into clinical workflows, and subsequent service support are considered as a unified and continuous cycle.

Particular attention was given to solutions developed in partnership with Elekta, a global leader in radiation therapy. These included equipping oncology centers with high-tech equipment and establishing comprehensive service support systems. MIT plays an active role in developing radiation therapy infrastructure in Kazakhstan — to date, the company has supplied three linear accelerators and is currently implementing a project for the delivery and installation of an Elekta Versa HD linear accelerator at the Oncology and Surgery Center in Ust-Kamenogorsk.

The project is being implemented with the support of the “Kazakhstan Khalkyna” Foundation under a Resolution of the Government of the Republic of Kazakhstan. It will enable oncology patients in East Kazakhstan to access advanced radiation therapy techniques, including IMRT, VMAT, IGRT, and SBRT.

The meeting served as an important platform for dialogue between the government, the medical community, and the business sector, aimed at improving the accessibility of oncology care in Kazakhstan.